Cargando…

Benchmarking HIV Quality Measures Across US Payer Types

Despite advances in antiretroviral therapy (ART), human immunodeficiency virus (HIV) remains a significant issue in the United States. Early diagnosis, continuous treatment access/adherence, and long-term care engagement help patients benefit fully from ART; however, a shortfall in care engagement r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Priest, Julie L., Irwin, Debra E., Evans, Kristin A., Oglesby, Alan K., Brady, Brenna L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Mary Ann Liebert, Inc., publishers 2020
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7074887/ https://www.ncbi.nlm.nih.gov/pubmed/31305206 http://dx.doi.org/10.1089/pop.2019.0052

Ejemplares similares

Benchmarking HIV Quality Measures in the US OPERA HIV Cohort
por: Heglar, Robert, et al.
Publicado: (2019)

Payer leverage and hospital compliance with a benchmark: a population-based observational study
por: Hollingsworth, John M, et al.
Publicado: (2007)

588. Retrospective Analysis of Clinical Characteristics and Treatment Patterns Among HIV Patients with Commercial and Medicare Advantage Health Insurance in the United States
por: Priest, Julie, et al.
Publicado: (2018)

The economic burden of pulmonary arterial hypertension (PAH) in the US on payers and patients
por: Sikirica, Mirko, et al.
Publicado: (2014)

Score to door time: a benchmarking tool for rapid response systems
por: Subbe, C, et al.
Publicado: (2010)

Values-Based Foundation for a U.S. Single Payer Health System Model
por: Markowitz, Walter, et al.
Publicado: (2021)

Comparing Real-World Healthcare Costs Associated with Single-Tablet Regimens for HIV-1: The 2-Drug Regimen Dolutegravir/Lamivudine vs. Standard 3- or 4-Drug Regimens
por: Priest, Julie, et al.
Publicado: (2023)

Hospitals and the Tax-Payer
Publicado: (1920)

Quality measures for protein alignment benchmarks
por: Edgar, Robert C.
Publicado: (2010)

Comment on: “Cost-Utility Analysis of Duloxetine in Osteoarthritis: A US Private Payer Perspective”
por: Liedgens, Hiltrud, et al.
Publicado: (2013)

US public and private payer coverage for tobacco cessation treatments and barriers to accessing treatments
por: Hussain, Radha, et al.
Publicado: (2022)

Trends in Out-of-Pocket Costs for Naloxone by Drug Brand and Payer in the US, 2010-2018
por: Peet, Evan D., et al.
Publicado: (2022)

Cost–effectiveness of overactive bladder treatments from a US commercial and payer perspective
por: Murray, Brian, et al.
Publicado: (2023)

Benchmarking the performance of US Municipalities
por: O’Loughlin, Caitlin T., et al.
Publicado: (2021)

A cost–benefit analysis of smoking cessation prescription coverage from a US payer perspective
por: Baker, Christine L, et al.
Publicado: (2018)

A Private Payer Persective
por: Shurney, Dexter W.
Publicado: (2006)

Changes in Payer Mix and Physician Reimbursement After the Affordable Care Act and Medicaid Expansion
por: Jones, Christine D., et al.
Publicado: (2015)

Denosumab for Elderly Men with Osteoporosis: A Cost-Effectiveness Analysis from the US Payer Perspective
por: Silverman, Stuart, et al.
Publicado: (2015)

Application of Economic Analyses in U.S. Managed Care Formulary Decisions: A Private Payer's Experience
por: Watkins, John B., et al.
Publicado: (2006)

2512. Decreasing Adherence to Antiretroviral Therapy over 4 Years of Follow-up in a Commercially-Insured Population of Patients with HIV
por: Priest, Julie, et al.
Publicado: (2019)

Improving patient-reported measures in oncology: a payer call to action
por: Schmidt, Theresa, et al.
Publicado: (2021)

1019. Healthcare Resource Utilization and Cost of People Living with HIV (PLWH) in US Commercial and Medicare Advantage Health Plans
por: Priest, Julie, et al.
Publicado: (2020)

Assessment of Rheumatoid Arthritis Quality Process Measures and Associated Costs
por: Brady, Brenna L., et al.
Publicado: (2017)

All-payer ratesetting: Down but not out
por: Anderson, Gerard F.
Publicado: (1992)

Are payers treating orphan drugs differently?
por: Cohen, Joshua P., et al.
Publicado: (2014)

Payer-Negotiated Prices for Telemedicine Services
por: Wu, Shannon S., et al.
Publicado: (2022)

An integrated valuation model for payer and investor
por: Nuijten, Mark, et al.
Publicado: (2022)

Payer Perspectives on Health Technology Assessment
por: Watkins, John B.
Publicado: (2012)

Benchmarking Strategies for Measuring the Quality of Healthcare: Problems and Prospects
por: Lovaglio, Pietro Giorgio
Publicado: (2012)

Rural Healthcare Disparities in the United States: Can Our Payer Structures Help Us Get Upstream?
por: McGrath, Kelly
Publicado: (2023)

Characterization of Heavily Treatment-Experienced People With HIV and Impact on Health Care Resource Utilization in US Commercial and Medicare Advantage Health Plans
por: Priest, Julie, et al.
Publicado: (2021)

Use of Oritavancin in Moderate-to-Severe ABSSSI Patients Requiring IV Antibiotics: A U.S. Payer Budget Impact Analysis
por: Jensen, Ivar S., et al.
Publicado: (2016)

Variation in Private Payer Coverage of Rheumatoid Arthritis Drugs
por: Chambers, James D., et al.
Publicado: (2016)

Variability in Private Payer Medical Policies for Osteochondral Allograft Transplantation Demonstrates the Absence of Standardization in Medical Criteria Between Payers
por: Tabbaa, Suzanne M., et al.
Publicado: (2022)

Measuring and benchmarking the quality of two different organizational ways in delivering infant vaccination
por: Maurici, M., et al.
Publicado: (2016)

Managed care and inpatient mortality in adults: effect of primary payer
por: Hines, Anika L., et al.
Publicado: (2017)

Risk sharing arrangements for pharmaceuticals: potential considerations and recommendations for European payers
por: Adamski, Jakub, et al.
Publicado: (2010)

Assessing payer perspectives on health information exchange
por: Cross, Dori A, et al.
Publicado: (2016)

Patient and Payer Preferences for Additional Value Criteria
por: Jakab, Ivett, et al.
Publicado: (2021)

Pharmaceutical Technology Assessment: Perspectives from Payers
por: Leung, Musetta Y., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_v4no4pu5d7r4hvjqmpjsur19vp